Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|November 11, 2022
Translational Implications for Radiosensitizing Strategies in RhabdomyosarcomaSilvia Pomella, Antonella Porrazzo, Matteo Cassandri, et al.
Cancers|June 22, 2023
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in RhabdomyosarcomaSilvia Pomella, Sara G Danielli, Rita Alaggio, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer CellsAnnalisa Romanelli, Giulia Stazi, Rossella Fioravanti, et al.
Clinical Epigenetics|August 8, 2015
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcomaSerena Vella, Silvia Pomella, Pier Paolo Leoncini, et al.
Iscience|May 17, 2020
Miswired Enhancer Logic Drives a Cancer of the Muscle LineageBerkley E Gryder, Marco Wachtel, Kenneth Chang, et al.
Nature Communications|July 10, 2019
Chemical genomics reveals histone deacetylases are required for core regulatory transcriptionBerkley E Gryder, Lei Wu, Girma M Woldemichael, et al.
International Journal of Molecular Sciences|October 13, 2021
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma CellsMatteo Cassandri, Silvia Pomella, Alessandra Rossetti, et al.
Cell Death Discovery|March 28, 2026
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancerSimone Ielpo, Francesca Barberini, Alice Gaiba, et al.
Frontiers in Cell and Developmental Biology|February 9, 2023
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiationClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
European Journal of Medicinal Chemistry|May 7, 2022
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular modelsMartina Menna, Francesco Fiorentino, Biagina Marrocco, et al.
Pageof 5